<script type="application/ld+json"> {"@context":"https://schema.org/", "@type":"Physician", "name":"François Quénet", "url":"https://myacare.com/doctor/dr-francois-quenet-spain", "description":"Dr. François Quénet is an expert in digestive and hepatobiliary surgery and is currently practicing at QS Teknon Medical Center. He specializes in the treatment of tumors of the liver and bile ducts, including surgery for liver metastases and complex retroperitoneal tumors.", "medicalSpecialty":["Oncologist","Liver Cancer Treatment Specialist","Pediatric Oncologist","Digestive Diseases Specialist"], "memberOf":[{ "@type":"MedicalClinic","name":"QS Teknon Medical Center", "url":"https://myacare.com/healthcare-provider/teknon-medical-center-barcelona-spain" }] },] </script> <style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Fran&ccedil;ois Qu&eacute;net is an expert in digestive and hepatobiliary surgery and is currently practicing at QS Teknon Medical Center. He specializes in the treatment of tumors of the liver and bile ducts, including surgery for liver metastases and complex retroperitoneal tumors.</p> <p>Dr. Qu&eacute;net is also the Head of the Hepatobiliary Surgery and Peritoneal Carcinomatosis Unit of the ICM Surgery Department. He has helped develop the PIPAC program, a procedure designed for patients with peritoneal carcinomatosis, and is also the principal investigator of peritoneal carcinomatosis clinic research which includes:</p> <ul> <li>The multicenter phase III &quot;PRODIGY 7&quot; research</li> <li>NIPOX phase I study: Induction therapy</li> <li>FLUOCAR study evaluating the toxicity of SGM 101, anti-ACE monoclonal antibody associated with a fluorochrome</li> </ul> Read More

<script type="application/ld+json"> {"@context":"https://schema.org/", "@type":"Physician", "name":"David S Kwon", "url":"https://myacare.com/doctor/dr-david-s-kwon-united-states", "description":"Dr. Kwon specializes in assessment, treatment planning and surgical services in a multidisciplinary setting", "medicalSpecialty":["Oncologist","Pancreatic Cancer Surgery Specialist","Surgical Oncology Specialist","Cytoreductive Cancer Surgery for HIPEC Specialist","Surgical Oncologist."], "memberOf":[{ "@type":"MedicalClinic","name":"Henry Ford Hospital", "url":"https://myacare.com/healthcare-provider/henry-ford-hospital-united-states" }] },] </script> <style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p><strong>Biographical Statement:</strong></p> <p>I specialize in Pancreatic Cancer Surgery, Surgical Oncology and Cytoreductive Cancer Surgery for HIPEC</p> <p>Dr. David Kwon is a board-certified surgeon and fellowship-trained surgical oncologist. He received his undergraduate degree in Biological Sciences from Columbia University and earned his medical degree from the University of California, San Diego. He completed his residency in general surgery at Henry Ford Hospital where he received multiple research and clinical awards. He completed a surgical oncology fellowship at the University of Texas, M.D. Anderson Cancer Center where he developed clinical expertise in the multidisciplinary care of cancer patients.</p> <p>Dr. Kwon&#39;s clinical interests focus on the care and surgical management, including cytoreductive cancer surgery for HIPEC, of patients with upper gastrointestinal malignancies, including gastric, duodenal, biliary, and pancreatic cancers.</p> <p><strong>Care Philosophy:</strong></p> <p>Dr. Kwon specializes in assessment, treatment planning, and surgical services in a multidisciplinary setting. He&rsquo;s dedicated to providing compassionate care for his patients, while perfecting new techniques to improve survival, shorten recovery times and minimize treatment-related side effects. He treats all his patients with the utmost respect and works with them in a supportive and relaxed atmosphere to provide the best possible care.</p> <p><strong>Research Interests:</strong></p> <p>Dr. Kwon&#39;s research is focused on surgical quality of care, outcomes, and racial disparities. He hopes to translate his findings to improve the overall care of cancer patients.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Hemanth is a qualified Surgical Oncologist in Old airport road, Bangalore. Some of his focal areas of interest includes:</p> <ul> <li>Advanced laparoscopic oncosurgery (Thorax, upper gastrointestinal, and colorectal)&nbsp;</li> <li>Pancreaticobiliary surgery</li> <li>Minimally invasive gynecological oncology</li> <li>Minimally Invasive Thoracic and GI Oncosurgery</li> <li>HIPEC (Hyperthermic intraperitoneal chemotherapy)</li> <li>Gynec and Breast Oncology</li> </ul> <p>After his post doctoral training (MCh), he has undergone further advanced surgical training in the following places:</p> <ul> <li>Advanced laparoscopic upper GI surgery for cancer in Seoul National University Hospital (SNUH), South Korea</li> <li>Trained in Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) at National University Hospital, Singapore</li> <li>Laparoscopic Esophageal Surgery training in Basavatarakam Indo-American Cancer Hospital and Research Center, Hyderabad&nbsp;</li> <li>Trained in Advanced peritonectomy and management of Peritoneal Surface Malignancy by European Society of Surgical Oncology (ESSO)</li> </ul> <p>He currently has 9 years of cumulative teaching experience and is actively involved in training five MCh residents every year. During his current tenure as Assistant Professor, he has actively initiated and standardized newer treatments and protocols in patient treatment and cares like ERAS (Enhanced Recovery After Cancer Surgery), Sentinel Lymph Node Biopsy in Endometrial and Cervical cancer, VEIL (Video endoscopic ileo inguinal groin dissection) and Minimally Invasive Gastric and Esophageal cancer surgery.</p> <p>Dr. Hemanth has a strong academic inclination. He has over 10 publications in peer-reviewed journals and is also a reviewer of research articles and recent advances for the prestigious Indian Journal of Surgical Oncology (IJSO) for the past 4 years. He himself has pioneered a new surgical technique for reducing delayed gastric emptying (DGE) after Whipple&rsquo;s pancreaticoduodenectomy and published the technique, and is now part of research activity for improving Quality of Life post-Whipple&rsquo;s procedure.</p> Read More

<script type="application/ld+json"> {"@context":"https://schema.org/", "@type":"Physician", "name":"Rupen A Shah", "url":"https://myacare.com/doctor/dr-rupen-a-shah-united-states", "description":"Dr. Shah specializes in endocrine neoplasms, including thyroid, parathyroid, and adrenal tumors. ", "medicalSpecialty":["General Surgical Oncology Specialist","Oncologist Surgeon","Endocrine Neoplasms Specialist","hyperthermic intraperitoneal chemotherapy (HIPEC) Specialist"], "memberOf":[{ "@type":"MedicalClinic","name":"Henry Ford Hospital", "url":"https://myacare.com/healthcare-provider/henry-ford-hospital-united-states" }] },] </script> <style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p><strong>Biographical Statement:</strong></p> <p>Dr. Shah recently completed his fellowship in Complex General Surgical Oncology at Roswell Park Cancer Institute in Buffalo, N.Y. During that time, Dr. Shah completed a research fellowship through the Surgical Outcomes Club focused on assessing perioperative patient outcomes using large national databases.</p> <p>Dr. Shah specializes in endocrine neoplasms, including thyroid, parathyroid, and adrenal tumors. He will help oversee management of peritoneal surface malignancies, including pseudomyxoma peritonei, mesothelioma, and select stage IV cancers with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC). Additionally, Dr. Shah will offer other regional therapies such as isolated limb infusion for select advanced melanoma and sarcoma.</p> Read More

<script type="application/ld+json"> {"@context":"https://schema.org/", "@type":"Physician", "name":"Arun Karanwal", "url":"https://myacare.com/doctor/dr-arun-karanwal-united-arab-emirates", "description":"Dr. Arun Karanwal is a renowned Medical Oncologist with more than five years of experience in his field.", "medicalSpecialty":["Medical Oncologist","Hematologist","Specialist in immunotherapies","Specialist in Tumors"], "memberOf":[{ "@type":"MedicalClinic","name":"Prime Hospital", "url":"https://myacare.com/healthcare-provider/prime-hospital-united-arab-emirates" }] },] </script> <style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Arun Karanwal is a renowned Medical Oncologist with more than five years of experience in his field. He earned his MBBS, MD, and DM (Medical Oncology) degrees in India. After completing his DM residency, he worked as a full time Consultant Medical Oncologist and Hematologist in one of the leading private hospitals in India for four years. In Dubai, he was a Specialist-Medical Oncologist in a private hospital where he headed a team of experts who formed the institution&rsquo;s own oncology unit.</p> <p>Over the course of his career, Dr. Arun has handled all kinds of oncology cases, including solid tumors in breast, lung colon, cervix, ovary, and head and neck; acute leukemias; and lymphomas. After diagnosis, he plans multimodality treatment and palliative and supportive care for his patients coupled with recommendations addressing their emotional and psychological needs as well as that of their families.</p> <p>He has a vast experience in managing chemotherapy drugs, targeted therapies, monoclonal anti-bodies, and immunotherapies. He has also done numerous bone marrow aspiration/biopsies, therapeutic lumbar punctures, and intraperitoneal chemotherapy administration. Dr. Arun, who published several of his research articles in prestigious international journals, has done multiple CME activities.</p> Read More

<script type="application/ld+json"> {"@context":"https://schema.org/", "@type":"Physician", "name":"Juan José Torrent", "url":"https://myacare.com/doctor/dr-juan-jose-torrent-spain", "description":"Dr. Juan José Torrent is a consultant gynecologist at Teknon Medical Center and Hospital El Pilar-Quironsalud, Barcelona, Spain. His main area of focus is the surgical treatment of peritoneal carcinomatosis of ovarian origin.", "medicalSpecialty":["Obstetrics and Gynecology Specialist","Gynecologist","Hyperthermic Intraperitoneal Chemotherapy HIPEC Specialist","Specialist in Laparoscopic Surgery"], "memberOf":[{ "@type":"MedicalClinic","name":"QS Teknon Medical Center", "url":"https://myacare.com/healthcare-provider/teknon-medical-center-barcelona-spain" }] },] </script> <style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Juan Jos&eacute; Torrent is a Gynecologist Consultant at Hospital El Pilar-Quironsalud, Barcelona and Quenet Torrent Institute Comprehensive Cancer Center. His main area of focus is the surgical treatment of peritoneal carcinomatosis of ovarian origin and is the main researcher of the European clinical studies on the treatment of peritoneal carcinomatosis by cytoreduction surgery and HIPEC.</p> <p>He also participated in the development of clinical studies on gynecological cancer and new intraperitoneal chemotherapy techniques, HIPEC and PIPAC.</p> <p>Some of his major collaborations are:</p> <ul> <li>Surgeon collaborator in Centre Val d&rsquo;Aurelle, Montepellier, since Jan 2009 to present, participating in the carcinomatosis/HIPEC program, with Dr Fran&ccedil;ois Quenet</li> <li>Gynecologist collaborator in Institut Claudius Regaud, Toulouse, France since Mar 2004 to 2009, participating in the development of new laparoscopic techniques and HIPEC program</li> <li>Gynecologist collaborator in Hospital El Pilar Quironsalud, Barcelona, Spain (private sector) since 2002</li> <li>International expert in the work group RENAPE for good practices in Pseudomyxoma Peritonei and Peritoneal Mesotelioma</li> <li>Key Opinion Leader of Johnson and Johnson for Techniques in peritoneal carcinomatosis and laparoscopic techniques</li> </ul> Read More